International Biotechnology Trust PLC Portfolio Holdings

International Biotechnology Trust PLC

  • $295 Million
  • Q3 2023

International Biotechnology Trust PLC has filed its 13F form on November 14, 2023 for Q3 2023 where it was disclosed a total value porftolio of $295 Million distributed in 65 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Amgen Inc with a value of $21.3M, Incyte Corp with a value of $20.7M, Gilead Sciences, Inc. with a value of $17.5M, Intra Cellular Therapies, Inc. with a value of $16.6M, and Biomarin Pharmaceutical Inc with a value of $13.6M.

Examining the 13F form we can see an decrease of $26.2M in the current position value, from $321M to 295M.

International Biotechnology Trust PLC is based out at London, X0

Below you can find more details about International Biotechnology Trust PLC portfolio as well as his latest detailed transactions.

Portfolio value $295 Million
Healthcare: $295 Million

Stock Holdings Table Market Cap. of $200 Billions or more

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$206B
$3.15 Million 1.07% of portfolio
46,500
Q3 2023 New

Summary

  • Portfolio
  • No. of Stocks 65
  • Current Value $295 Million
  • Prior Value $321 Million
  • Filing
  • Period Q3 2023
  • Filing Date November 14, 2023
  • Form Type 13F-HR
  • Activity in Q3 2023
  • New Purchases 9 stocks
  • Additional Purchases 18 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 13 stocks
Track This Portfolio

Track International Biotechnology Trust PLC Portfolio

Follow International Biotechnology Trust PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

News

Stay updated on International Biotechnology Trust PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email